NYSE and NASDAQ Stock Price Targets and Analyst Ratings

Stay on top of the latest NYSE- and NASDAQ-listed stock analyst recommendations with our up-to-date list of stock price targets and analyst ratings. This page tracks newly issued analyst ratings, price targets, upgrades, downgrades, and other broker actions to help you see how Wall Street analysts view U.S. companies. Use these ratings to compare sentiment, spot shifts in outlook, and make more informed investment decisions.

On This Page:FAQ

Company	Action	Brokerage	Analyst	Current Price	Price Target	Rating
ALKS Alkermes	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ami Fadia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$48.11 +4.5%	$54.00 ➝ $61.00	Buy
AMD Advanced Micro Devices	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Timothy Arcuri Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$519.85 -5.8%	$455.00 ➝ $670.00	Buy
APGE Apogee Therapeutics	Reiterated by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Catanzaro Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$132.88 +0.2%	$110.00 ➝ $135.00	Outperform ➝ Neutral
AR Antero Resources	Target Set by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Betty Jiang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$34.54 +1.5%	$45.00
ARGX argenex	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Harrison Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$853.40 -5.6%	$1,170.00 ➝ $1,180.00	Overweight
AVTR Avantor	Reiterated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Luke Sergott Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$9.41 +0.6%		Underweight
AVTR Avantor	Target Set by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$9.41 +0.6%	$8.00
BB BlackBerry	Initiated by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Suthan Sukumar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$8.82 +0.3%	$12.00	Buy
BLZE Backblaze	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mike Cikos Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$11.66 +43.6%	$8.50 ➝ $14.00	Buy
BLZE Backblaze	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$11.66 +43.6%		Outperform
A drilling crew just broke a record nobody expected (Ad) A drilling crew in Beaver County, Utah hit 15,765 feet of solid granite in 16 days - a job the Department of Energy projected would take 64. They reached DOE's 2035 performance targets twelve years early, cutting costs in half within 18 months. When Congress moved to cut solar and wind tax credits, this energy source kept its full credits through 2033. One company has been building in this space for sixty years, and a July 4th catalyst is now 12 days away. See the company at the center of Project FORGE right now
BRKR Bruker	Reiterated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Luke Sergott Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$55.11 -2.5%		Overweight
BRKR Bruker	Target Set by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Dan Leonard Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$55.11 -2.5%	$60.00
BRZE Braze	Target Set by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gabriela Borges Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$19.26 +0.3%	$34.00
CBRS Cerebras Systems	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	N. Quinn Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$227.34 +1.3%	$300.00	Buy
CBRS Cerebras Systems	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Moore Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$227.34 +1.3%	$250.00 ➝ $273.00	Overweight
CBRS Cerebras Systems	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Timothy Arcuri Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$227.34 +1.3%		Buy
CCL Carnival	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brandt Montour Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$28.75 -4.8%	$36.00 ➝ $35.00	Overweight
CCL Carnival	Reiterated by	Susquehanna Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Christopher Stathoulopoulos Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$28.75 -4.8%		Positive
CE Celanese	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Cunningham Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$48.02 -3.4%		Buy
CLSK Cleanspark	Initiated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$17.19 -1.5%		Outperform
CLYM Climb Bio	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.30 +1.0%	$20.00	Buy
COUR Coursera	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan MacDonald Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$5.42 +2.1%	$10.00	Buy
ECL Ecolab	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Cunningham Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$268.83 -0.2%		Buy
ECVT Ecovyst	Initiated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Cunningham Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.78 -0.9%		Neutral ➝ Overweight
ENTX Entera Bio	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1.55 +4.7%		Buy
FDX FedEx	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Thomas Wadewitz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$319.06 -3.0%		Buy
FDX FedEx	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ariel Rosa Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$319.06 -3.0%		Buy
FLS Flowserve	Downgraded by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$80.02 -1.9%		Buy ➝ Hold
FRO Frontline	Target Raised by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gregory Lewis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$42.85 +3.1%	$45.00 ➝ $55.00	Buy
FRVO Fervo Energy	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Anderson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$32.96 -9.4%	$47.00 ➝ $48.00	Overweight
FRVO Fervo Energy	Target Set by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$32.96 -9.4%	$48.00
FTRE Fortrea	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Luke Sergott Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$16.47 +5.8%	$16.00 ➝ $18.00	Equal Weight
GH Guardant Health	Reiterated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Luke Sergott Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$130.83 +1.6%		Overweight
GH Guardant Health	Target Set by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$130.83 +1.6%	$150.00
HRMY Harmony Biosciences	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$34.16 +2.2%		Buy
ICLR Icon	Target Set by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$142.67 +1.4%	$160.00
ILMN Illumina	Reiterated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Luke Sergott Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$164.93 +2.2%		Underweight
INCY Incyte	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mitchell S. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$104.40 +0.7%	$140.00	Buy
INSW International Seaways	Target Raised by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gregory Lewis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$90.03 +1.8%	$90.00 ➝ $100.00	Buy
INVH Invitation Home	Upgraded by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Feldman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$29.11 +2.4%	$31.00 ➝ $33.00	Sector Perform ➝ Overweight
Solar is dead. Here’s what replaces it. (Ad) Starting July 4th, every new solar and wind project in America loses its federal tax credits. But one zero-carbon energy source retains full government backing for eight more years - and it runs around the clock without batteries. Investment in this sector has surged 100x in seven years. The Pentagon named it a top energy priority, California mandated it, and Google, Meta, and Berkshire Hathaway are already under contract. One company controls the entire chain from the ground to the grid. See the last clean energy source with full government backing
IT Gartner	Reiterated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Haas Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$129.25 +2.8%		Underweight
KBH KB Home	Reiterated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sam Reid Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$52.59 +0.1%		Underweight
KEEL Keel Infrastructure	Initiated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$6.60 -0.9%		Outperform
KFY Korn/Ferry International	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Marcon Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$71.97 +6.2%	$84.00 ➝ $85.00	Outperform
KVYO Klaviyo	Target Set by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Callie Valenti Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.57 +5.5%	$26.00
LIN Linde	Initiated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Cunningham Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$512.90 -0.7%		Buy ➝ Overweight
NKE NIKE	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Paul Lejuez Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$42.49 -1.6%		Neutral
NTRA Natera	Target Set by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$234.76 +2.6%	$260.00
NUE Nucor	Upgraded by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Philip Gibbs Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$239.40 -2.3%	$274.00	Sector Weight ➝ Overweight
NUVL Nuvalent	Downgraded by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jeffrey Walch Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$123.44 +0.0%	$172.00 ➝ $124.00	Outperform ➝ Market Perform
OGE OGE Energy	Initiated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Arcaro Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$48.40 +1.5%	$50.00	Equal Weight
OKTA Okta	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mike Cikos Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$118.16 +1.9%	$120.00 ➝ $140.00	Buy
OVV Ovintiv	Reiterated by	Roth Mkm Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$55.02 +0.7%	$55.00	Neutral
PFG Principal Financial Group	Reiterated by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joshua Shanker Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$112.36 +1.0%	$98.00 ➝ $95.00	Neutral ➝ Underperform
PFG Principal Financial Group	Downgraded by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$112.36 +1.0%		Sell ➝ Underperform
PMN Promis Neurosciences	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$10.69 +0.1%	$18.00	Buy
PRCT PROCEPT BioRobotics	Initiated by	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$20.60 -2.2%		Outperform
PSBD Palmer Square Capital BDC	Initiated by	Noble Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$10.74 +0.4%		Neutral
QUBT Quantum Computing	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$10.49 -0.5%		Neutral
RDDT Reddit	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Laura Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$165.24 -3.1%	$300.00	Buy
RS Reliance	Reiterated by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Samuel McKinney Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$398.21 -1.3%	$378.00 ➝ $418.00	Overweight
SHC Sotera Health	Reiterated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Luke Sergott Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$15.84 +0.6%		Overweight
SHC Sotera Health	Target Set by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$15.84 +0.6%	$19.00
SHO Sunstone Hotel Investors	Reiterated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Cooper Clark Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$11.74 -1.0%		Overweight
SHW Sherwin-Williams	Initiated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Cunningham Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$323.51 +2.1%		Buy ➝ Overweight
SLGL Sol-Gel Technologies	Initiated by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Uy Ear Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$71.26 -3.4%	$285.00	Outperform
SLN Silence Therapeutics	Initiated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$7.27 -3.5%		Overweight
STLD Steel Dynamics	Reiterated by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Samuel McKinney Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$243.69 -2.9%	$241.00 ➝ $262.00	Overweight
TTWO Take-Two Interactive Software	Initiated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Clark Lampen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$242.64 +1.3%	$290.00	Buy
TWLO Twilio	Initiated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$184.49 +0.5%		Buy
TWST Twist Bioscience	Reiterated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Luke Sergott Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$85.00 -0.2%	$95.00	Overweight
TXG 10x Genomics	Reiterated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Luke Sergott Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$31.87 -3.2%	$40.00	Overweight
UBSI United Bankshares	Initiated by	Hovde Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$45.29 +0.8%	$49.00	Market Perform
USPH U.S. Physical Therapy	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$63.65 +1.8%		Market Outperform
UWMC UWM	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Douglas Harter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$2.04 -0.5%	$4.00	Buy
VRNS Varonis Systems	Upgraded by	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Todd Weller Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$35.03 +7.1%	$33.00 ➝ $45.00	Equal Weight ➝ Overweight
VSTM Verastem	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jeet Mukherjee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$4.21 -0.9%	$18.00	Buy
VSTM Verastem	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andres Y. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$4.21 -0.9%	$18.00	Buy
VVX V2X	Downgraded by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Gesuale Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$83.31 +1.6%		Outperform ➝ Market Perform
ZETA Zeta Global	Target Set by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$19.49 +5.5%	$28.00
ZVRA Zevra Therapeutics	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$13.00 +2.8%		Buy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 09:00 AM ET.

Frequently Asked Questions

Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports and conversations with company executives.

Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell."

Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere.

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

NYSE and NASDAQ Stock Price Targets and Analyst Ratings

Frequently Asked Questions